MariMed Inc (MRMD)
OTHER OTC:MRMD
MRMDMariMed
$0.94
$0.027 (2.92%)

MariMed Stock Analysis & Ratings

MariMed Stock Analysis Overview

Smart Score
6
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The MariMed stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

MRMD

MRMD Stock Stats

Previous Close$0.91
Open$0.89
Bid0 x 0
Ask0 x 0
Today’s Range$0.89 - $0.9548
52-Week Range$0.13 - $1.20
Volume421.86K
Average Volume836.66K
Market Cap$302.23M
Beta3.85
P/E Ratio33.3
EPS0.03
Earnings DateAug 17, 2021

Company Description

MariMed Inc

MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. The company develops precision-dosed cannabis-infused products designed for specific medical conditions and related symptoms. Its products are licensed under brands of Kalm Fusion, Betty's Eddies, and Nature's Heritage, in the form of dissolvable strips, tablets, powders, microwaveable popcorn, and fruit chews. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
Sector
Basic Materials
Industry
Biotechnology
CEO
Robert Fireman
Employees
12
Address
26 Ossipee Road, Newton, MA, 02464, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

MRMD FAQ

What was MariMed’s price range in the past 12 months?
MariMed lowest stock price was $0.13 and its highest was $1.20 in the past 12 months.
    What is MariMed’s market cap?
    MariMed’s market cap is $302.23M.
      What is MariMed’s price target?
      Currently, no data Available
      What do analysts say about MariMed?
      Not enough analysts have published a price target to provide an average price target.
      When is MariMed’s upcoming earnings report date?
      MariMed’s upcoming earnings report date is Aug 17, 2021 which is in 21 days.
        How were MariMed’s earnings last quarter?
        MariMed released its earnings results on May 17, 2021. The company reported $0.012 earnings per share for the quarter, beating the consensus estimate of N/A by $0.012.
          Is MariMed overvalued?
          According to Wall Street analysts MariMed’s price is currently Overvalued.
            Does MariMed pay dividends?
            MariMed does not currently pay dividends.
            What is MariMed’s EPS estimate?
            MariMed’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does MariMed have?
            MariMed has 322,730,000 shares outstanding.
              What happened to MariMed’s price movement after its last earnings report?
              MariMed reported an EPS of $0.012 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.22%.
                Which hedge fund is a major shareholder of MariMed?
                Currently, no hedge funds are holding shares in MRMD

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis